These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 34486740)

  • 1. Neonatal outcome and adaption after in utero exposure to antidepressants: A systematic review and meta-analysis.
    Kautzky A; Slamanig R; Unger A; Höflich A
    Acta Psychiatr Scand; 2022 Jan; 145(1):6-28. PubMed ID: 34486740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal Discontinuation Syndrome in Serotonergic Antidepressant-Exposed Neonates.
    Yang A; Ciolino JD; Pinheiro E; Rasmussen-Torvik LJ; Sit DKY; Wisner KL
    J Clin Psychiatry; 2017 May; 78(5):605-611. PubMed ID: 28570796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.
    Singal D; Brownell M; Chateau D; Ruth C; Katz LY
    BMJ Open; 2016 Nov; 6(11):e013293. PubMed ID: 27899401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations Between Maternal Depression, Antidepressant Use During Pregnancy, and Adverse Pregnancy Outcomes: An Individual Participant Data Meta-analysis.
    Vlenterie R; van Gelder MMHJ; Anderson HR; Andersson L; Broekman BFP; Dubnov-Raz G; El Marroun H; Ferreira E; Fransson E; van der Heijden FMMA; Holzman CB; Kim JJ; Khashan AS; Kirkwood BR; Kuijpers HJH; Lahti-Pulkkinen M; Mason D; Misra D; Niemi M; Nordeng HME; Peacock JL; Pickett KE; Prady SL; Premji SS; Räikkönen K; Rubertsson C; Sahingoz M; Shaikh K; Silver RK; Slaughter-Acey J; Soremekun S; Stein DJ; Sundström-Poromaa I; Sutter-Dallay AL; Tiemeier H; Uguz F; Varela P; Vrijkotte TGM; Winterfeld U; Zar HJ; Zervas IM; Prins JB; Pop-Purceleanu M; Roeleveld N
    Obstet Gynecol; 2021 Oct; 138(4):633-646. PubMed ID: 34623076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.
    Oberlander TF; Warburton W; Misri S; Aghajanian J; Hertzman C
    Arch Gen Psychiatry; 2006 Aug; 63(8):898-906. PubMed ID: 16894066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes.
    Lund N; Pedersen LH; Henriksen TB
    Arch Pediatr Adolesc Med; 2009 Oct; 163(10):949-54. PubMed ID: 19805715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications.
    Moses-Kolko EL; Bogen D; Perel J; Bregar A; Uhl K; Levin B; Wisner KL
    JAMA; 2005 May; 293(19):2372-83. PubMed ID: 15900008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurobehavioral assessment of infants born at term and in utero exposure to serotonin reuptake inhibitors.
    Smith MV; Sung A; Shah B; Mayes L; Klein DS; Yonkers KA
    Early Hum Dev; 2013 Feb; 89(2):81-6. PubMed ID: 22999988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paediatric outcomes following intrauterine exposure to serotonin reuptake inhibitors: a systematic review.
    Fenger-Grøn J; Thomsen M; Andersen KS; Nielsen RG
    Dan Med Bull; 2011 Sep; 58(9):A4303. PubMed ID: 21893008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newborn neurobehavioral patterns are differentially related to prenatal maternal major depressive disorder and serotonin reuptake inhibitor treatment.
    Salisbury AL; Wisner KL; Pearlstein T; Battle CL; Stroud L; Lester BM
    Depress Anxiety; 2011 Nov; 28(11):1008-19. PubMed ID: 21898709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal Outcomes in Women With Untreated Antenatal Depression Compared With Women Without Depression: A Systematic Review and Meta-analysis.
    Jarde A; Morais M; Kingston D; Giallo R; MacQueen GM; Giglia L; Beyene J; Wang Y; McDonald SD
    JAMA Psychiatry; 2016 Aug; 73(8):826-37. PubMed ID: 27276520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Poor Neonatal Adaptation Syndrome Among Infants Exposed to Second-Generation Atypical Antipsychotics Compared to Antidepressants: Results From the National Pregnancy Registry for Psychiatric Medications.
    Viguera AC; McElheny SA; Caplin PS; Kobylski LA; Rossa ET; Young AV; Gaccione P; Góez-Mogollón L; Freeman MP; Cohen LS
    J Clin Psychiatry; 2023 Jan; 84(1):. PubMed ID: 36602927
    [No Abstract]   [Full Text] [Related]  

  • 13. Obstetrical and neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitors: the relevance of dose.
    Roca A; Garcia-Esteve L; Imaz ML; Torres A; Hernández S; Botet F; Gelabert E; Subirà S; Plaza A; Valdés M; Martin-Santos R
    J Affect Disord; 2011 Dec; 135(1-3):208-15. PubMed ID: 21890210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of perinatal exposures on the infant: antidepressants and depression.
    Hanley GE; Oberlander TF
    Best Pract Res Clin Obstet Gynaecol; 2014 Jan; 28(1):37-48. PubMed ID: 24100223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infant serotonin transporter (SLC6A4) promoter genotype is associated with adverse neonatal outcomes after prenatal exposure to serotonin reuptake inhibitor medications.
    Oberlander TF; Bonaguro RJ; Misri S; Papsdorf M; Ross CJ; Simpson EM
    Mol Psychiatry; 2008 Jan; 13(1):65-73. PubMed ID: 17519929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development.
    Casper RC; Gilles AA; Fleisher BE; Baran J; Enns G; Lazzeroni LC
    Psychopharmacology (Berl); 2011 Sep; 217(2):211-9. PubMed ID: 21499702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis.
    Masarwa R; Bar-Oz B; Gorelik E; Reif S; Perlman A; Matok I
    Am J Obstet Gynecol; 2019 Jan; 220(1):57.e1-57.e13. PubMed ID: 30170040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of prenatal exposure to serotonin reuptake inhibitors or maternal major depressive disorder on infant developmental outcomes.
    Santucci AK; Singer LT; Wisniewski SR; Luther JF; Eng HF; Dills JL; Sit DK; Hanusa BH; Wisner KL
    J Clin Psychiatry; 2014 Oct; 75(10):1088-95. PubMed ID: 25373117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Birth outcomes following prenatal exposure to antidepressants.
    Pearson KH; Nonacs RM; Viguera AC; Heller VL; Petrillo LF; Brandes M; Hennen J; Cohen LS
    J Clin Psychiatry; 2007 Aug; 68(8):1284-9. PubMed ID: 17854255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates.
    Ferreira E; Carceller AM; Agogué C; Martin BZ; St-André M; Francoeur D; Bérard A
    Pediatrics; 2007 Jan; 119(1):52-9. PubMed ID: 17200271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.